Pathogenesis of neonatal Streptococcus agalactiae infections

Microbes and Infection

Volumn 2, Issue 14, 2000, Pages 1733-1742

  Spellerberg, B ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Group B streptococci; Infectious diseases; Neonatal infections; Pathogenesis; Streptococcus agalactiae

Indexed keywords

BACTERIAL POLYSACCHARIDE; HEMOLYSIN; HYALURONIC ACID; PROTEIN C; VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; FATALITY; INFECTION PREVENTION; NEWBORN INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS AGALACTIAE;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 0033637467     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)01328-9     Document Type: Review

References (125)

1. A national survey of severe group B streptococcal infections in neonates and young infants in Denmark
2. Neonatal septicemia due to group B streptococci-Perinatal risk factors and outcome of subsequent pregnancies
3. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms
4. Multistate case control study of maternal risk factors for neonatal group B streptococcal disease
5. Prevention of perinatal group B streptococcal disease: A public health perspective
6. Changing epidemiology of group B streptococcal colonization
7. Group B streptococcus (GBS) colonisation among expectant Irish mothers
8. Capsular polysaccharides types of group B streptococcal isolates from neonates with early onset systemic infection
9. Invasive disease due to group B streptococcus in pregnant women and neonates from diverse population groups
10. Serotype VI and VIII predominate among group B streptococci isolated from pregnant Japanese women
11. Neonatal sepsis caused by a new streptococcal serotype
12. Invasive group B streptococcal disease: The emergence of serotype V
13. Structural and immunochemical characterization of the type VIII group B streptococcus polysaccharide
14. Immunochemistry of the capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (Group B streptococcus)
15. Structure of the native polysaccharide antigens of type Ia and type Ib group B streptococcus
16. Structural determination of the capsular polysaccharide antigen of type II group B streptococci
17. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B streptococcus
18. Isolation and characterization of type IV group B Streptococcus capsular polysaccharide
19. Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide
20. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide
21. A sialic acid-specific lectin from Cepaea hortensis that promotes phagocytosis of a group-B, type Ia streptococcal strain
22. Assessment of the virulence factors of group B streptococci: Correlation with sialic acid content
23. Identification of a genetic locus essential for capsule sialylation in type III group B streptococcus
24. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection
25. Definition of a bacterial virulence factor: Sialylation of the group B streptococcal capsule
26. Prevention of C 3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci
27. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci
28. Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression
29. Characterization of the capsular polysaccharide genes of group B streptococci
30. Cell growth rate regulates expression of group B streptococcus type III capsular polysaccharide
31. The effects of growth in human serum on an acapsular group B streptococcus mutant
32. Analysis of the capsule synthesis locus, a virulence factor in group B streptococci
33. Identification of two genes, cpsX and cpsY, with putative regulatory function on capsule expression in group B streptococci
34. Early onset group B streptococal disease: Clinical, roentgeno graphic, and pathologic features
35. Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells
36. A comparative serological study of streptolysins derived from human and animal infections with note on pneumococcal hemolysin, tetanolysin and streptococcal toxin
37. Properties of a hemolysin produced by group B streptococci
38. Hemolysin produced by group B Streptococcus agalactiae
39. Pigment production by Lancefield group B streptococci (Streptococcus agalactiae)
40. Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition
41. Identification of a novel insertion sequence element in Streptococcus agalactiae
42. Group B streptococcal Ibc protein antigen; distribution of two determinants in wild-type strains of common serotypes
43. Protein Rib: A novel Group B Streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections
44. A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the α c protein
45. Phenotypic diversity in the alpha C protein of group B streptococci
46. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci
47. Neonatal group B streptococcal infection in Mallorca, Spain
48. Group B Streptococci escape host immunity by deletion of tandem repeat elements of the alpha c protein
49. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice
50. Identification of an immunoglobulin A binding motif located in the β-antigen of the c-protein complex of group B streptococci
51. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein
52. Cloned alpha and beta C protein antigens of group B streptococci elicit protective immunity
53. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes
54. Group B streptococci inhibit the chemotactic activity of the fifth component of complement
55. Conservation of the C5a peptidase genes in group A and B streptococci
56. A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections
57. A note on a lytic phenomenon shown by group B streptococci
58. Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor gene
59. Identification, cloning, and expresion of the CAMP factor gene (cfa) of group A streptococci
60. Unspecific binding of group B streptococcal cocytolysin (CAMP-factor) to immunoglobulins and its possible role in pathogenicity
61. Lethal effect of CAMP-factor and UBERIS-factor - A new finding about diffusible exosubstances of Streptococcus agalactiae and Streptococcus uberis
62. Role of CAMP-factor (proteinB) for virulence
63. Cloning and expression of the gene for group B streptococcal hyaluronate lyase
64. The Streptococcus agalactiae hylB gene encoding hyaluronate lyase: Completion of the sequence and expression analysis
65. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci
66. Identification of a novel insertion element IS1548, in Group B streptococci, predominantly in strains causing endocarditis
67. GBS enzymes, homolysins, toxins and other products
68. Risk factors in early onset neonatal group B streptococcal infections
69. Amniotic fluid infections with intact membranes leading to perinatal death: A prospective study
70. Bacterial attachment to the chorioamniotic membranes
71. Pulmonary changes in neonatal sepsis to group B beta-hemolytic Streptococcus: Relation of hyaline membrane disease
72. Prospective studies of group B streptococcal infections in infants
73. Untersuchung zur Haufigkeit von B-Streptokokkenerkrankungen und-Besiedlung eine klinisch epidemiologische Studie
74. Vaginal infections and prematurity study group
75. Adherence of group B streptococci to cultured epithelial cells: Roles of environmental factors and bacterial surface components
76. Adherence of Group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoid acid
77. Role of hydrophobic surface proteins in mediating adherence of group B streptococci to epithelial cells
78. Adherence of group B streptococcci to human endothelial cells in vitro
79. The adhesin structures involved in the adherence of group B streptococci to human vaginal cells
80. Adherence of Streptococcus agalactiae to synchronously growing human cell monlayers without Lipoteichoic acid involvement
81. Role of cellular lipoteichoic acids in mediating the adherence of Serotype III strains of group B streptococci to human embryonic, fetal and adult epithelial cells
82. Teichoic acids of Streptococcus agalactiae: Chemistry, cytotoxicity, and effect on bacterial adherence to human cells in tissue culture
83. Multiple adhesins of streptococci
84. Group B streptococci adhere to a variant of fibronectin attached to a solid phase
85. Characterization of partially purified group B streptococcal clumping factor
86. Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin
87. Respiratory cell invasion by group B streptococci
88. Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: Evidence for bacterial cellular invasion
89. Characterization of group B streptococcal invasion in Hep-2 epithelial cells
90. Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells in vitro
91. Group B streptococci invade endothelial cells: Type III capsular polysaccharide attenuates invasion
92. Correlation of epithelial cell invasiveness of group B streptococci with clinical source of isolation
93. Studies of group B streptococcal infection in mice deficient in complement component C3 and C4 demonstrate an essential role for complement in both innate and acquired immunity
94. Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway
95. Capsular polysaccharide regulates neutrophil complement receptor inter-actions with type III group B streptococci
96. Variation in repeat number within the alpha c protein of group B streptococci alters antigenicity and protective epitopes
97. Group B streptococci persist inside macrophages
98. Immunofluorescence in group B streptococcal infection and idiopathic respiratory distress syndrome
99. A comparison of early-onset group B streptococcal neonatal infection and the respiratory distress syndrome of the newborn
100. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits
101. Experimental neonatal group B streptococcal pneumonia: Effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits
102. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection
103. Role of pulmonary phagocytes in host defense against group B streptococci in preterm versus term rabbit lung
104. Intrapulmonary bacterial clearance of type III group B streptococcus is reduced in preterm compared with term rabbits and occurs independent of antibody
105. Effects of the thromboxane synthetase inhibitor, dazmegrel (UK 38,485) on pulmonary gas exchange and the hemodynamics in neonatal sepsis
106. Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci
107. Soluble antigens from group B streptococci induce cytokine production in human blood cultures
108. Interleukin 6 production by human neonatal monocytes stimulated by type III group B streptococci
109. Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci
110. Involvement of CD14 and complement receptor CR3 and CR4 in nuclear factorkappaB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls
111. Cytokine response to group B streptococcus infection in mice
112. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci
113. Beneficial effects of interluekin-6 in neonatal mouse models of group B streptococcal disease
114. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection
115. Role of gamma interferon in a neonatal mouse model of group B streptococcal disease
116. Brain injury in experimental neonatal meningitis due to group B streptococci
117. Biochemical mediators of meningeal inflammatory response to group B streptococcus in the newborn piglet model
118. The induction of meningeal inflammation by components of pneumococcal cell wall
119. Oxygen free radicals and the cerebral arteriolar response to group B streptococci
120. Effect of group B streptococcal meningitis on retinal blood and choroidal blood flow in newborn pigs
121. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci
122. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis